Published on 2 Apr 2023 on Simply Wall St. via Yahoo Finance
Provention Bio, Inc. (NASDAQ:PRVB) Just Reported And Analysts Have Been Cutting Their Estimates
Provention Bio, Inc. (NASDAQ:PRVB) just released its latest full-year results and things are looking bullish. Revenues of US$13m beat estimates by a substantial 39% margin. Unfortunately, Provention Bio also reported a statutory loss of US$1.52 per share, which at least was smaller than the analysts expected. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Provention Bio after the latest results.
See our latest analysis for Provention Bio
